Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Lygos
AddedFeb 13, 2024
UpdatedJun 18, 2026
Lygos

Lygos

Lygos: Biotech firm transforming sugar into valuable chemicals via engineered yeast.

HQ
Berkeley, CA, US
Founded
2011
Accelerator
Y Combinator logoY CombinatorW16
Overview
Compare
Fundraising
Employees
Website

Founded in 2010, Lygos is a biotechnology company dedicated to addressing renewable chemical challenges by engineering microbes to convert sugars into high-value industrial chemicals. Their core mission is to replace petrochemical production with cost-advantaged biological processes. Lygos offers solutions across various sectors, including agronomy, home care, personal care, water treatment, fragrances, and coatings, focusing on sustainable and efficient production methods.

Lygos has attracted notable investors and industry leaders who support its innovative approach to biotechnology. The company has achieved significant milestones in developing microbial strains that enhance production efficiency and reduce environmental impact. By providing sustainable alternatives to traditional chemical manufacturing, Lygos has made a substantial impact on the industrial chemicals market, promoting greener and more cost-effective solutions.

Lygos - Similar Companies

Zymochem logo

Zymochem

zymochem.com

Ginkgo Bioworks logo

Ginkgo Bioworks

ginkgobioworks.com

Solugen logo

Solugen

solugen.com

Wild Microbes logo

Wild Microbes

wildmicrobes.com

Industrial Microbes logo

Industrial Microbes

imicrobes.com

Xylogenics logo

Xylogenics

xylogenics.com

Modular Genetics logo

Modular Genetics

Glycos Biotechnologies logo

Glycos Biotechnologies

glycosbio.com

Genomatica logo

Genomatica

genomatica.com

Pow.bio logo

Pow.bio

pow.bio

Bluumbio logo

Bluumbio

bluumbio.com

Capra Biosciences logo

Capra Biosciences

Amyris logo

Amyris

amyris.com

Lytos Technologies logo

Lytos Technologies

lytostech.com

Yali Bio logo

Yali Bio

yali.bio

Lygos - Quick Facts

Who are Lygos' competitors?

Companies similar to Lygos include Zymochem, Ginkgo Bioworks, Solugen and Wild Microbes.

When was Lygos founded?

Lygos was founded in 2011.

Where is Lygos' headquarters located?

Lygos' headquarters is located in Berkeley, CA, US.

When was Lygos' last funding round?

Lygos' most recent funding round was for $160M (USD) in April 2022.

How much has Lygos raised to-date?

As of Apr 18, 2022, Lygos has raised a total of $211.5M (USD).

How many employees does Lygos have?

Lygos has 75 employees as of Feb 5, 2024.

Lygos - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Licensing
  • Recurring
Customer
  • Enterprise
Main Product
  • Chemicals
  • Ingredients
Tags
  • Cleantech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified